Carlsmed, Inc.

CARLCIK 0001794546 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Feb 25, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:No prior 10-KFull-doc fallback

Full filing:tone -0.0204

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 5, 2026no items parsed Feb 25, 2026no items parsed Jan 12, 2026no items parsed Nov 6, 2025no items parsed Oct 30, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Carlsmed, Inc.

Name	Roles	Filings
Cordonnier Michael	OfficerDirector	3
Casey Niall	OfficerDirector	2
Durall William Scott	Officer	2
Greenstein Leonard M.	Officer	2
B Capital Group Management, L.P.	10% Owner	1

Showing 1-5 of 17

Per pagePage 1 of 4Next

All filings

16 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 4, 2026	Cordonnier Michael CEO, President · Director	SSale	197,855	$13.292	$2,629,889
Jan 30, 2026	Greenstein Leonard M. CFO, Treasurer	AGrant	44,977	$0.00	$0
Jan 30, 2026	Cordonnier Michael CEO, President · Director	AGrant	117,316	$0.00	$0
Jan 30, 2026	Casey Niall Chief IP Officer · Director	AGrant	44,977	$0.00	$0
Jan 30, 2026	Durall William Scott Chief Commercial Officer	AGrant	44,977	$0.00	$0

Showing 1-5 of 16